RWA Wealth Partners LLC Acquires New Position in STERIS plc (NYSE:STE)

RWA Wealth Partners LLC acquired a new stake in shares of STERIS plc (NYSE:STE - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,727 shares of the medical equipment provider's stock, valued at approximately $561,000.

Other institutional investors have also modified their holdings of the company. Principal Financial Group Inc. grew its position in shares of STERIS by 9.5% in the third quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider's stock valued at $270,230,000 after purchasing an additional 96,336 shares in the last quarter. Public Sector Pension Investment Board grew its holdings in STERIS by 13.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 4,283 shares of the medical equipment provider's stock valued at $1,039,000 after buying an additional 500 shares in the last quarter. Atom Investors LP grew its holdings in STERIS by 37.8% in the 3rd quarter. Atom Investors LP now owns 3,716 shares of the medical equipment provider's stock valued at $901,000 after buying an additional 1,020 shares in the last quarter. Hilltop Holdings Inc. acquired a new stake in shares of STERIS in the 3rd quarter worth $218,000. Finally, Investment Management Corp of Ontario boosted its position in shares of STERIS by 55.4% during the 3rd quarter. Investment Management Corp of Ontario now owns 3,365 shares of the medical equipment provider's stock valued at $816,000 after acquiring an additional 1,200 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

STERIS Stock Down 3.7 %

NYSE:STE traded down $8.25 during midday trading on Friday, hitting $213.16. 1,201,030 shares of the company were exchanged, compared to its average volume of 533,170. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The company has a market capitalization of $20.94 billion, a PE ratio of 45.26 and a beta of 0.87. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The company has a fifty day simple moving average of $223.23 and a 200 day simple moving average of $220.44.

Remove Ads

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, equities analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date was Thursday, February 20th. STERIS's payout ratio is currently 48.41%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on STE. Stephens reaffirmed an "overweight" rating and set a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. JMP Securities reissued a "market outperform" rating and set a $265.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, Piper Sandler upped their price target on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, STERIS currently has a consensus rating of "Moderate Buy" and a consensus target price of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.